Sanuwave Health announces debt refinancing with new credit facility

Sanuwave Health (SNWV) announced refinancing of its $27.5 million debt facility with NH Expansion Credit Fund Holdings with a new secured credit facility from J.P. Morgan consisting of a $23.0 million term loan, which amortizes over four years and a two-year $5.0 million receivables backed revolving credit facility from which the Company drew approximately $1.0 million at closing. Both facilities have an interest rate of SOFR +350bp and neither facility has any prepayment penalties. The use of proceeds for the $24 million borrowing at closing was the partial repayment of the NH Expansion debt facility. The remaining $3.5M owed on the NH Expansion debt facility and additional transaction and initiation costs of approximately $1.3 million were repaid using cash accumulated from the Company’s operations and from its sale of certain intravascular shockwave patents disclosed in the Company’s Current Report on 8-K filed on August 21, 2025.